Yesterday’s EPLAW webinar discussed the topic of proportionality and final injunctions, it was entitled: Proportionality why not… but are there true alternatives to a final injunction? The session was moderated by Sabine Agé (Hoyng ROKH Monegier, FR). Panellistst were: Domien Op de Beeck – Bird&Bird, BE Ida Gjessing – Gjessing Reimers, NO Ari Laakkonen – […]
FOUND IN: BLOGThis year’s congress will be taking place on Friday 26 November, 2021 from 9:00am to 3:30pm (CET) at: The Hotel Brussels 38 Boulevard de Waterloo 1000 Bruxelles Belgium Please register using the link provided in the Eventbrite invitation. Invites were sent to all EPLAW members on 13 October (sender EPLAW), please check with your IT […]
FOUND IN: CONGRESSLonghi (Netherlands) Trading B.V. v. Hanwa Solutions Corporation, PI Judge District Court Rotterdam, 1 October 2021, Case no. ECLI:NL:RBROT:2021:9551 Proceedings regarding solar panels. Longhi’s solar panels are stored in the Netherlands and distributed worldwide from the Netherlands. A cross border injunction is issued against Longi forbidding Longi to infringe Hanwa’s patents, or to be involved […]
FOUND IN: BLOGOptis Cellular v Apple Retail [2021] EWHC 2564 (Pat) In a lengthy and complex decision reaching over 80 pages, Mr Justice Meade has given judgment in the latest in a series of trials in the UK’s Patents Court between the claimants (“Optis”) and defendants (“Apple”) concerning Optis’ standard essential patents (SEPs) and the FRAND obligations […]
FOUND IN: BLOGSisvel International S.A. v. Shenzhen Tinno Mobile Technology Corporation, Wiko SAS et al., interlocutory judgment District Court of The Hague, 21 April 2021, Case No. ECLI:NL:RBDHA:2021:8955 Sisvel holds EP 2 139 272, relating to a ‘Method and system for attaching a mobile equipment to a wireless communication network’. Sisvel reported EP 272 as essential patent […]
FOUND IN: BLOGIntroduction With Decision No. 1785 of 8 June 2021, the Court of Appeal of Milan upheld Court of Milan Decision No. 8273 of 24 July 2018 finding Teva Pharmaceutical Industries Ltd. (“Teva”) and its Italian affiliate Sicor Società Italiana Corticosteroidi S.r.l (“Sicor”) liable for patent infringement. The appeal court ruled that the Bolar exemption under […]
FOUND IN: BLOG
EMAIL US
